149 related articles for article (PubMed ID: 23831019)
41. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
[TBL] [Abstract][Full Text] [Related]
42. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
43. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog.
Kim SP; Ellmerer M; Van Citters GW; Bergman RN
Diabetes; 2003 Oct; 52(10):2453-60. PubMed ID: 14514627
[TBL] [Abstract][Full Text] [Related]
44. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
[TBL] [Abstract][Full Text] [Related]
45. Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet.
Nonogaki K; Kaji T
Sci Rep; 2020 Sep; 10(1):15784. PubMed ID: 32978487
[TBL] [Abstract][Full Text] [Related]
46. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
49. Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls.
Vienberg SG; Brøns C; Nilsson E; Astrup A; Vaag A; Andersen B
Eur J Endocrinol; 2012 Jul; 167(1):49-57. PubMed ID: 22529197
[TBL] [Abstract][Full Text] [Related]
50. Response of fibroblast growth factor 21 to meal intake and insulin infusion in patients on maintenance haemodialysis.
Reinhard M; Frystyk J; Jespersen B; Randers E; Bibby BM; Ivarsen P
Clin Endocrinol (Oxf); 2015 Aug; 83(2):187-95. PubMed ID: 25659979
[TBL] [Abstract][Full Text] [Related]
51. Pharmacologic stimulation of central GLP-1 receptors has opposite effects on the alterations of plasma FGF21 levels induced by feeding and fasting.
Nonogaki K; Kaji T; Yamazaki T; Murakami M
Neurosci Lett; 2016 Jan; 612():14-17. PubMed ID: 26683903
[TBL] [Abstract][Full Text] [Related]
52. Interplay between FGF21 and insulin action in the liver regulates metabolism.
Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR
J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271
[TBL] [Abstract][Full Text] [Related]
53. [Mechanisms of the role of fibroblast growth factor 21 in attenuating insulin resistance].
Xu TY; Wang WF; Xu PF; Yuan QY; Liu SQ; Zhnag T; Ren GP; Li DS
Yao Xue Xue Bao; 2015 Sep; 50(9):1101-6. PubMed ID: 26757545
[TBL] [Abstract][Full Text] [Related]
54. [Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism].
Zhu SL; Zhang ZY; Ren GP; Ye XL; Ma L; Yu D; Han MM; Zhao JZ; Zhang TY; Li DS
Yao Xue Xue Bao; 2013 Dec; 48(12):1778-84. PubMed ID: 24689234
[TBL] [Abstract][Full Text] [Related]
55. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
[TBL] [Abstract][Full Text] [Related]
56. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
[TBL] [Abstract][Full Text] [Related]
57. Alterations in 3-Hydroxyisobutyrate and FGF21 Metabolism Are Associated With Protein Ingestion-Induced Insulin Resistance.
Harris LLS; Smith GI; Patterson BW; Ramaswamy RS; Okunade AL; Kelly SC; Porter LC; Klein S; Yoshino J; Mittendorfer B
Diabetes; 2017 Jul; 66(7):1871-1878. PubMed ID: 28473464
[TBL] [Abstract][Full Text] [Related]
58. Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats.
Tanajak P; Pongkan W; Chattipakorn SC; Chattipakorn N
Diab Vasc Dis Res; 2018 May; 15(3):263-269. PubMed ID: 29424246
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding.
Loyd C; Magrisso IJ; Haas M; Balusu S; Krishna R; Itoh N; Sandoval DA; Perez-Tilve D; Obici S; Habegger KM
J Appl Physiol (1985); 2016 Sep; 121(3):687-98. PubMed ID: 27445299
[TBL] [Abstract][Full Text] [Related]
60. TM-25659-Induced Activation of FGF21 Level Decreases Insulin Resistance and Inflammation in Skeletal Muscle via GCN2 Pathways.
Jung JG; Yi SA; Choi SE; Kang Y; Kim TH; Jeon JY; Bae MA; Ahn JH; Jeong H; Hwang ES; Lee KW
Mol Cells; 2015 Dec; 38(12):1037-43. PubMed ID: 26537193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
